GENEVA, July 2 -- RUBIX THERAPEUTICS, INC. filed a patent application (US2025/059665) for “MODULATORS OF RXFP1 AND METHODS OF USE THEREOF”. With publication no. WO/2026/136248, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07C 233/11
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....